Century Therapeutics, Inc. (NASDAQ:IPSC), featuring a year-to-date gain of 114.11% and upside potential of 134.70%, secures a spot on our list of hot biotech stocks under $5 to buy. New preclinical ...

The latest price target for Century Therapeutics (NASDAQ:IPSC) was reported by Leerink Partners on November 17, 2025. The analyst firm set a price target for $2.00 expecting IPSC to rise to within 12 ...

MGM Targets saw a need for development of a versatile, durable and economical target to better facilitate tactical / personal protection training while being mindful of the household budget. The ...

Researchers across discovery and translational biomedicine recognize the critical importance of iPSCs in core applications beyond regenerative medicine. Large, global biobanks offer researchers ...

Shares of Century Therapeutics, Inc. (IPSC) have gained 9.7% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term ...